Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer164
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review162
New Developments in VHL-Associated Neuroendocrine Neoplasms128
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review114
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors86
Immunotherapy in Biliary Tract Cancers: Where Are We?78
Brain Prehabilitation for Oncologic Surgery64
Surgical Management of Melanoma: Advances and Updates59
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers51
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas51
NRG1 Fusions: The New Kid on the Block47
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications45
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances44
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain41
Treatment of Metastatic Melanoma in the Elderly41
Fatty Acid Metabolism and Cancer Immunotherapy40
Management of Upper Tract Urothelial Carcinoma40
Management of In-Transit Metastases40
Head and Neck Mucosal Melanoma: Where Are We Now?39
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites38
Surgical Stress and Cancer Progression: New Findings and Future Perspectives36
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting35
Anti-PD-1: When to Stop Treatment33
The Microbiome in Advanced Melanoma: Where Are We Now?33
Engineered T Cells: CAR T Cell Therapy and Beyond33
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients33
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications32
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan32
An Overview of Angiogenesis in Bladder Cancer32
Cellular Therapy in NSCLC: Between Myth and Reality31
Current Trends and Challenges of Microbiome Research in Prostate Cancer30
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients30
The Difficult Airway in Patients with Cancer30
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review29
AXL Inhibitors: Status of Clinical Development29
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?29
Appendiceal Neuroendocrine Neoplasms: an Update for 202328
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors28
Targeting the PI3K Pathway in Gynecologic Malignancies28
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours28
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?27
Cancer Pain Management—New Therapies26
Proton Therapy in The Treatment of Head And Neck Cancers- Review26
CAR-T Therapies in Solid Tumors: Opportunities and Challenges25
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations25
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies25
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy25
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations24
Geographical Disparities in Colorectal Cancer in Canada: A Review24
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases23
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma23
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer23
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question23
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review23
Surgery for Recurrent Epithelial Ovarian Cancer22
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews22
Helping Patients Understand and Cope with BRCA Mutations22
Current Management of Neuroendocrine Tumour Liver Metastases22
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing22
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions22
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials21
Vascular Inflammation, Cancer, and Cardiovascular Diseases21
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)21
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer21
Development of Effective Siglec-9 Antibodies Against Cancer21
Evolving Treatment Approaches to Mucosal Melanoma21
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia20
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets20
Small Cell and Other Rare Histologic Types of Cervical Cancer20
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction20
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer19
Management of Peripheral T-cell Lymphomas and the Role of Transplant19
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?19
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity19
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic18
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging18
Ependymoma: Evaluation and Management Updates18
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions18
Current Diagnostic Tools for Breast Cancer-Related Lymphedema18
Elderly Rectal Cancer: An Updated Review18
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy17
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review17
Multimodality Therapies for Localized Prostate Cancer17
History of Leukemia, Revisited17
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights17
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review17
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review17
Statins for Cardiac and Vascular Protection During and After Cancer Therapy17
Intratumoral Immunotherapy: Is It Ready for Prime Time?17
Current Status on Management of Primary Plasma Cell Leukemia17
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours16
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy16
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma16
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers16
Return to Intended Oncological Therapy: State of the Art and Perspectives16
Richter’s Transformation16
Epidemiology of Cancer in Older Adults: A Systematic Review16
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions15
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge15
Bystander effect of antibody–drug conjugates: fact or fiction?15
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development15
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives15
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment15
Racial Disparities in Breast Cancer: from Detection to Treatment15
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies15
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment15
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer15
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations14
Viral and Clinical Oncology of Head and Neck Cancers14
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL14
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?14
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas14
CDK4/6 inhibitors: The Devil is in the Detail14
The Role and Impact of Minimal Residual Disease in NSCLC14
Is Myelodysplasia a Consequence of Normal Aging?14
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine13
Lymphatic Interventions in the Cancer Patient13
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer13
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science13
Cardio-Oncology in Childhood: State of the Art13
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer13
Current Role of Functional Imaging in the Management of Lymphoma13
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway13
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer13
Clinicopathological Review of Micropapillary Urothelial Carcinoma13
Advances in Treatment of Waldenström Macroglobulinemia13
CAR T-cell Therapy for Central Nervous System Lymphoma13
0.12315201759338